A65
朝食ＢｉｆｉＸ（ビフィックス）ヨーグルト脂肪ゼロ
江崎グリコ株式会社販売休止中
加工食品(その他)
Category
Notif. Date
2015-06-24
Planned Sale Date
Functional Claim
本品にはビフィズス菌BifiX(B. lactis GCL2505)が含まれます。ビフィズス菌BifiXは生きて腸まで届き、腸内で増殖することで、腸内環境を改善することが報告されています。
Functional Ingredient
Content
Functional Claim
本品にはビフィズス菌BifiX(B. lactis GCL2505)が含まれます。ビフィズス菌BifiXは生きて腸まで届き、腸内で増殖することで、腸内環境を改善することが報告されています。
AI Summary
Automatically generated from notification documents
This zero-fat yogurt contains BifiX probiotic (B. lactis GCL2505), which has been reported to survive to the intestine and proliferate there, potentially supporting a healthy intestinal environment.
Key Features
[
"
S
u
r
v
i
v
e
s
t
o
t
h
e
i
n
t
e
s
t
i
n
e
"
,
"
P
r
o
l
i
f
e
r
a
t
e
s
i
n
g
u
t
"
,
"
Z
e
r
o
f
a
t
"
,
"
F
o
c
u
s
o
n
i
n
t
e
s
t
i
n
a
l
h
e
a
l
t
h
"
]
For those interested in gut health.
Recommended ProductsPR
広告: A8.net
Notification Documents
| Product Name | 朝食ＢｉｆｉＸ（ビフィックス）ヨーグルト脂肪ゼロ |
| Category | |
| Food Classification | 加工食品(その他) |
| Functional Ingredient Name | ビフィズス菌BifiX(B. lactis GCL2505) |
| Functional ingredient is an extract | No |
| Functional Claim | 本品にはビフィズス菌BifiX(B. lactis GCL2505)が含まれます。ビフィズス菌BifiXは生きて腸まで届き、腸内で増殖することで、腸内環境を改善することが報告されています。 |
| Consumer Affairs Department Contact | |
| Information Disclosure Website URL |
| (1) Precautions for Intake | |
| (2) Safety Evaluation Method | |
| (3) Notifier's Safety Evaluation |
| Details |
| (1) Functionality Evaluation Method | |
| (2) Notifier's Functionality Evaluation |
| Reason for not classifying as tablet/capsule food | |
| Primary Target Audience | |
| Planned Sales Start Date | |
| Change History (before Mar 31, 2025) | |
| Change History (from Apr 1, 2025) | |
| Before/After Comparison Table | |
| Before/After Comparison Table (attachments) | |
| If re-notification | No |
| Existing Notification Number | |
| Reason for Maintaining Identity | |
| Post-notification Sales Status | 販売休止中 |
| Reason for Notification Withdrawal |
| Month of Last Self-Inspection Report |